Gene · 4100
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quantifying tumor specificity using Bayesian probabilistic modeling for drug target discovery and prioritization. | bioRxiv | 2023 | 36945433 | PubTator, text mining | PubMed |
| Unified model-free interaction screening via CV-entropy filter. | Comput Stat Data Anal | 2023 | 36910335 | PubTator, text mining | PubMed |
| Transcriptional analysis links B cells and TERT expression to favorable prognosis in head and neck cancer. | PNAS Nexus | 2023 | 36909826 | PubTator, text mining | PubMed |
| B Cells in Breast Cancer Pathology. | Cancers (Basel) | 2023 | 36900307 | PubTator, text mining | PubMed |
| Identification of Prognostic Biomarkers for Suppressing Tumorigenesis and Metastasis of Hepatocellular Carcinoma through Transcriptome Analysis. | Diagnostics (Basel) | 2023 | 36900109 | PubTator, text mining | PubMed |
| Toxicomethylomics revisited: A state-of-the-science review about DNA methylation modifications in blood cells from workers exposed to toxic agents. | Front Public Health | 2023 | 36891347 | PubTator, text mining | PubMed |
| Immunotherapy associated central nervous system complications in primary brain tumors. | Front Oncol | 2023 | 36874119 | PubTator, text mining | PubMed |
| Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer. | Front Oncol | 2023 | 36874112 | PubTator, text mining | PubMed |
| Myosin-X recruits lamellipodin to filopodia tips. | J Cell Sci | 2023 | 36861887 | PubTator, text mining | PubMed |
| Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment. | Bone Res | 2023 | 36849442 | PubTator, text mining | PubMed |
| Peptide Vaccines in Melanoma: Chemical Approaches towards Improved Immunotherapeutic Efficacy. | Pharmaceutics | 2023 | 36839774 | PubTator, text mining | PubMed |
| mRNA-From COVID-19 Treatment to Cancer Immunotherapy. | Biomedicines | 2023 | 36830845 | PubTator, text mining | PubMed |
| Enhancing Efficacy of TCR-engineered CD4 + T Cells Via Coexpression of CD8α. | J Immunother | 2023 | 36826388 | PubTator, text mining | PubMed |
| A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients. | Int J Mol Sci | 2023 | 36768214 | PubTator, text mining | PubMed |
| Epigenetic Perspective of Immunotherapy for Cancers. | Cells | 2023 | 36766706 | PubTator, text mining | PubMed |
| Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies. | Cancers (Basel) | 2023 | 36765928 | PubTator, text mining | PubMed |
| Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability. | Nat Commun | 2023 | 36765089 | PubTator, text mining | PubMed |
| Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T. | Mol Cancer | 2023 | 36750830 | PubTator, text mining | PubMed |
| Improvement in the performance of an autoantibody panel in combination with heat shock protein 90a for the detection of early‑stage lung cancer. | Exp Ther Med | 2023 | 36741915 | PubTator, text mining | PubMed |
| Comprehensive Molecular Analyses of Notch Pathway-Related Genes to Predict Prognosis and Immunotherapy Response in Patients with Gastric Cancer. | J Oncol | 2023 | 36733672 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4100/papers?page=8